Investment in U.S. biotech startups has fallen to the lowest level in over 20 years, with an increasing share of venture capital flowing into AI-driven companies across various industries. This shift highlights changing priorities in the startup funding landscape, favoring AI innovations over traditional biotech ventures.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More